About US
Contact us
-
Biotech execs who pinched Genentech trade secrets headed to prisonTop execs at Taiwanese biosimilars outfit JHL Biotech are headed to prison after pleading guilty last August to stealing trade secrets from Roche’s Genentech. Racho Jordanov, co-founder and for2022/3/18
-
BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutinyThe U.S. securities watchdog has set the countdown timer for the delisting of three leading Chinese biotechs from the Nasdaq as a newly installed foreign audit law threatens to banish more Chinese fi2022/3/16
-
Fierce Pharma Asia—Legend CEO's cell therapy ambitions; Indian pharmas' awkward position; new Hutchmed CEOAfter its first commercial launch in Carvykti, Legend Biotech's CEO talked up the rising CAR-T star's cell therapy ambitions. The Indian government's reluctanceto take a harsh stance on Russia could2022/3/16
-
Lonza completes lab expansion at Chinese API production plantLonza completed a laboratoryexpansion projectat its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of2022/3/14
-
India's hesitance to condemn Russia puts the country's pharma industry in compromising positionRussia’s invasion of Ukraine has put India in a compromising position. To protect itself against China, India has courted favor with both the European Union and Russia. With those powers on opposing2022/3/14
-
Biogen starts layoff round as the Aduhelm maker struggles with Alzheimer's rolloutBiogen’s $500 million restructuring plan is starting to take a toll on its employees. The company has started sending out layoff letters to some employees in the U.S., Biogen said in a statemen2022/3/9
-
Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktailPfizer and BioNTech recently emerged from a lawsuit unscathed after Allele Biotechnology and Pharmaceuticals cried patent infringement against a trio of pandemic juggernauts. For Regeneron, however,2022/3/9
-
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its meritsWhile England’s drug-price watchdog continues to assess the value of Amgen’s lung cancer drug Lumykras, the company and the National Health Service havestrucka deal to make the groundbreaking treatme2022/3/7
-
Billionaire Sackler family enters $6B opioid deal with support from holdout statesWhen OxyContin maker Purdue Pharma and its founding family inked a $4.3 billion opioid settlement back in September 2021, the judge overseeing the casecalledit a "bitter result." Now, thanks to an ap2022/3/7
-
Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trialEli Lilly is headed to trial over claims it skimped on Medicaid rebate payments. U.S. District Judge Harry Leinenweber has shot down Lilly’s motion to end a 2014 whistleblower lawsuit, concludi2022/3/2